Dacomitinib is used for NSCLC, particularly in cases where there are specific EGFR mutations, like 19 deletion or 21 L858R. It’s just another EGFR inhibitor, you know, that stops those signals coming from EGFR. The drug is available as 15mg, 30mg, or 45mg film-coated tablets, with the recommended dose being 45mg taken once a day.
Each strength is for once a day and used to handle this lung cancer stuff in folks with certain EGFR mutations. Each bottle has 30 tablets in it. Dacomitinib is like a focused attack on these cancer cells that have the EGFR mutation.
